Advertisement

Chronische Hepatitis bei HBV-, HCV-, HIV-infizierten und koinfizierten Patienten mit angeborener Hämophilie A oder B

  • M. von Depka Prondzinski
  • A. Berger
  • S. Ehrenforth
  • I. Scharrer
  • B. Weber
Conference paper

Zusammenfassung

Mit Verfügbarkeit des Anti-HCV-Tests [1–3] stellte sich heraus, daß von einer hohen Prävalenz von HCV-Antikörpern, insbesondere bei Vorliegen einer chronisch viralen Hepatitis, unter Blut- und Blutprodukt-Empfängern auszugehen ist [4–14]. Ein erheblicher Anteil HCV-Infizierter muß mit der Entwicklung einer chronisch aktiven Hepatitis bzw. einer Leberzirrhose rechnen [14–18]. Auch das hepatozelluläre Karzinom scheint bei HCV-seropositiven Patienten häufiger vorzukommen [19–24]. Viele parenteral HCV-infizierte Hämophile sind zugleich HIV-infiziert [16, 25–27]. Indes ist unklar, welchen Einfluß eine HIV-Infektion auf den Verlauf einer durch HCV verursachten Hepatitis ausübt. Die Befürchtung, HIV könne bei HCV-Infizierten zu einer überdurchschnittlich häufigen bzw. raschen Entwicklung eines Leberversagens führen [28–32], veranlaßte diese retrospektive Untersuchung, die Klinik und Laborparameter HCV-infizierter und HIV-seropositiver Patienten einerseits und HIV-seronegativer Hämophiler andererseits vergleicht.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Kuo G, Choo CL, Alter HJ et al (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362PubMedCrossRefGoogle Scholar
  2. 2.
    Bonino E, Brunetto MR, Baldi M (1991) Hepatitis C, serology. Gastroent Hepatol 3: 580–584Google Scholar
  3. 3.
    Alter HJ (1992) New kit on the block: evaluation of second generation assays for detection of antibody to the hepatitis C virus. Hepatology 15: 350–352PubMedCrossRefGoogle Scholar
  4. 4.
    Grob PJ, Joller Jemelke HJ (1990) Hepatitis-C-Virus (HCV), Anti-HCV und Non- A-Non-B Hepatitis. Schweiz Med Wochenschr 120: 117–124PubMedGoogle Scholar
  5. 5.
    Roggendorf M, Deinhardt F, Rasshofer R et al (1989) Antibodies to hepatitis C virus (anti-HCV). Lancet 2: 324–325PubMedCrossRefGoogle Scholar
  6. 6.
    Esteban JI, Gonzales A, Hernandez JM et al (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323: 1107–1112PubMedCrossRefGoogle Scholar
  7. 7.
    Ludlam CA, Chapman D, Cohen BJ, Litton PA (1989) Antibodies to hepatitis C virus in haemophilia. Lancet 2: 560Google Scholar
  8. 8.
    Hatzakis A, Polychronaki H, Miriagou V et al (1992) Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders. Vox Sang 63: 204–209PubMedCrossRefGoogle Scholar
  9. 9.
    Watson HG, Ludlam CA, Rebus S et al (1992) Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates. Br J Haematol 80: 514–518PubMedCrossRefGoogle Scholar
  10. 10.
    Pistello M, Ceccherini-Nelli L, Cecconi N et al (1991) Hepatitis C virus seroprevalence in Italian haemophiliacs injected with virus-inactivated concentrates: five year follow-up and correlation with antibodies to other viruses. J Med Virol 33: 43–46PubMedCrossRefGoogle Scholar
  11. 11.
    Maisonneuve P, Laurian Y, Guerois C et al (1991) Antibody to hepatitis C (anti C 100-3) in French hemophiliacs. Nouv Rev Fr Hematol 33: 263–266PubMedGoogle Scholar
  12. 12.
    Brettler DB, Alter HJ, Dienstag JL et al (1990) Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 76: 254–256PubMedGoogle Scholar
  13. 13.
    Polywka S, Laufs R (1991) Hepatitis C virus antibodies among different groups at risk and patients with suspected non-A, non-B hepatitis. Infection 19: 81–84PubMedCrossRefGoogle Scholar
  14. 14.
    Esteban JI, Esteban R, Viladomiu L et al (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet 2: 294–297PubMedCrossRefGoogle Scholar
  15. 15.
    Sansonno D, Dammacco F (1989) Antibodies to hepatitis C virus in Non-A, Non-B post-transfusion and cryptogenetic chronic liver disease. Lancet 2: 798–799PubMedCrossRefGoogle Scholar
  16. 16.
    Makris M, Preston FE, Triger DR et al (1990) Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335: 1117–1119PubMedCrossRefGoogle Scholar
  17. 17.
    Hay CRM, Preston FE, Triger DR, Underwood JCE (1985) Progressive liver disease in haemophilia: an understated problem? Lancet 1: 1495–1497PubMedCrossRefGoogle Scholar
  18. 18.
    Dienstag JL (1983) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85: 439–462PubMedGoogle Scholar
  19. 19.
    Simonetti RG, Cottone M, Craxi A et al (1989) Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet 2: 1338PubMedCrossRefGoogle Scholar
  20. 20.
    Colombo M, Kuo G, Choo QL et al (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006–1008PubMedCrossRefGoogle Scholar
  21. 21.
    Bruix J, Barrera JM, Calvet X et al (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006PubMedCrossRefGoogle Scholar
  22. 22.
    Yu MC, Tong MJ, Coursaget P (1990) Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 82: 1038–1041PubMedCrossRefGoogle Scholar
  23. 23.
    Chiaramonte M, Farinati F, Fagiuoli S (1990) Antibody to hepatitis in hepatocellular carcinoma. Lancet 335: 301–302Google Scholar
  24. 24.
    Noel L, Guerois C, Maisonneuve P et al (1989) Antibodies to hepatitis C virus in haemophilia. Lancet 2: 560CrossRefGoogle Scholar
  25. 25.
    Troisi CL, Hollinger FB, Hoots WK et al (1993) A multicenter study of viral hepatitis in a United States hemophilic population. Blood 81: 412–418PubMedGoogle Scholar
  26. 26.
    Eyster ME, Diamondstone LS, Goedert J J (1992) Hepatic AIDS in persons with hemophilia coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The Multicenter Hemophilia Cohort Study. Int Conf AIDS 1992 July 19–24 8:B 164Google Scholar
  27. 27.
    Schulman S, Grillner L (1990) Antibodies against hepatitis C in a population of Swedish haemophiliacs and heterosexual partners. Scand J Infect Dis 22: 393–397PubMedCrossRefGoogle Scholar
  28. 28.
    Eyster ME, Diamondstone LS, Lien JM et al (1993) Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 6: 602–610PubMedGoogle Scholar
  29. 32.
    Martin P, Di Bisceglie AM, Kassianides C et al (1989) Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97: 1559–1561PubMedGoogle Scholar
  30. 33.
    Simmonds P, Zhang LQ, Watson HG et al (1990) Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 336: 1469–1472PubMedCrossRefGoogle Scholar
  31. 35.
    Watson HG, Zhang LQ, Simmonds P, Ludlam CA (1992) Hepatitis C virus load increases with time after HIV infection. Int Conf AIDS 1992 July 19–24 8: B195Google Scholar
  32. 36.
    Van der Poel CL, Reesink HW, Lelie PN et al (1989) Anti-hepatitis C antibodies and Non-A, Non-B post-transfusion hepatitis in the Netherlands. Lancet 2: 297–298PubMedGoogle Scholar
  33. 37.
    Leslie DE, Rann S, Nicholson S et al (1991) Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease. Med J Aust 156: 789–792Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • M. von Depka Prondzinski
  • A. Berger
  • S. Ehrenforth
  • I. Scharrer
  • B. Weber

There are no affiliations available

Personalised recommendations